Sinodata Co., Ltd. (002657.SZ) Bundle
Curious whether Sinodata Co., Ltd. (002657.SZ) is a turnaround story or a cautionary tale? In Q3 ending September 30, 2025 the company reported revenue of CNY 198.74 million (down 14.14% year‑over‑year), while trailing twelve‑month revenue sits at CNY 1.18 billion (up 35.17% YoY) and 2024 annual revenue was CNY 1.17 billion (a 16.46% increase), with revenue per employee about CNY 1.81 million across 650 staff; yet profitability remains under pressure after a H1 2025 net loss attributable to shareholders of CNY 84.95 million (a 71.51% increase) and H1 basic EPS of -0.2498 vs -0.15 a year earlier, even as analysts model EPS of -0.04/0.07/0.14 for 2025-2027 and forecast net income of CNY 0.22B, CNY 0.50B and CNY 0.87B for the same years; liquidity shows cash and equivalents of CNY 393.94 million (down 41.07%) with accounts receivable of CNY 225.05 million, valuation sits at a P/S of 8.87 and market cap of CNY 10.44 billion (share price CNY 29.72 as of Nov 5, 2025) alongside an analyst initiation at target CNY 29.21 with an "Outperform" rating-while risk flags include negative EBITDA, a 3.21% share drop on Oct 13, 2025, and a reported ROCE of 0% even as the company pivots into AI‑native architectures and expanded computing power services aimed at reigniting growth
Sinodata Co., Ltd. (002657.SZ) - Revenue Analysis
Sinodata reported revenue of CNY 198.74 million for the quarter ended September 30, 2025, a decline of 14.14% year-over-year. Despite the quarterly dip, trailing twelve months (TTM) revenue is CNY 1.18 billion, representing a 35.17% increase versus the prior year. The company's full-year 2024 revenue was CNY 1.17 billion, up 16.46% from 2023.
- Quarter (Q3 2025): CNY 198.74 million (-14.14% YoY)
- TTM revenue: CNY 1.18 billion (+35.17% YoY)
- 2024 annual revenue: CNY 1.17 billion (+16.46% YoY)
Operational and market context:
- Workforce: 650 employees, implying revenue per employee ≈ CNY 1.81 million.
- Market capitalization: CNY 10.44 billion, based on share price CNY 29.72 (as of 2025-11-05).
- Price-to-sales (P/S) ratio: 8.87, indicating the market values roughly CNY 8.87 of equity per CNY 1 of revenue.
| Metric | Value | Change / Note |
|---|---|---|
| Q3 2025 Revenue | CNY 198.74 million | -14.14% YoY |
| TTM Revenue | CNY 1.18 billion | +35.17% YoY |
| 2024 Revenue | CNY 1.17 billion | +16.46% YoY |
| Employees | 650 | Revenue/employee ≈ CNY 1.81 million |
| Market Cap | CNY 10.44 billion | Share price CNY 29.72 (2025-11-05) |
| P/S Ratio | 8.87 | Market valuation metric |
For broader corporate context and how revenue ties to Sinodata's business model, see: Sinodata Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money
Sinodata Co., Ltd. (002657.SZ) - Profitability Metrics
- Net loss attributable to shareholders (H1 2025): CNY 84.95 million (↑71.51% vs H1 2024).
- Basic EPS (H1 2025): loss of CNY 0.2498 (H1 2024: loss of CNY 0.15).
- Main drivers: decline in gross profit and increased operating expenses, leading to the reported net loss.
- Company status: currently in a profit recovery phase with expectations of improving margins in coming years.
| Metric | H1 2025 | H1 2024 | YoY Change |
|---|---|---|---|
| Net loss attributable to shareholders | CNY 84.95 million | (approx CNY 49.56 million) | +71.51% |
| Basic EPS | -CNY 0.2498 | -CNY 0.15 | Worsened |
| Gross profit trend | Declined (H1 2025) | Higher (H1 2024) | Negative impact on margins |
| Primary cost movement | Increased expenses (operating/other) | Lower | Raised loss |
- Analysts' EPS projections (company turnaround expectations):
| Year | Projected EPS (CNY) |
|---|---|
| 2025 | -0.04 |
| 2026 | 0.07 |
| 2027 | 0.14 |
- Implication: turnaround hinges on restoring gross profit margins and reining in expense growth; market expectations incorporate recovery over 2026-2027.
- For company strategic context and stated long-term direction, see Mission Statement, Vision, & Core Values (2026) of Sinodata Co., Ltd.
Sinodata Co., Ltd. (002657.SZ) - Debt vs. Equity Structure
Specific line-item breakdowns of Sinodata's debt and equity composition are not readily available in the sources reviewed. Nevertheless, assessing capital structure requires tracking a set of concrete metrics and signals. Below are the practical items investors should focus on and the current availability status where applicable.- Monitor total liabilities, short-term vs. long-term debt, and off‑balance‑sheet obligations.
- Track shareholders' equity, retained earnings, and any recent equity issuance or buybacks.
- Calculate leverage and coverage ratios regularly: debt/EBITDA, debt/equity, interest coverage (EBIT/interest expense).
- Watch liquidity metrics: current ratio and quick ratio to assess short-term repayment ability.
- Review financing costs and maturity schedule to evaluate refinancing and rollover risk.
| Metric | What to look for | Current disclosure status / guidance |
|---|---|---|
| Total Assets (RMB) | Foundation for leverage ratios (assets = liabilities + equity) | Not readily available in reviewed sources - check latest balance sheet |
| Total Liabilities (RMB) | Include short-term payables, long-term debt, lease liabilities | Not readily available - examine notes to financial statements |
| Shareholders' Equity (RMB) | Book equity used to compute debt/equity | Not readily available - disclosed on balance sheet |
| Debt/Equity Ratio | Measure of financial leverage; higher = more leverage risk | Not reported here - compute from most recent financials |
| Debt/EBITDA | Indicates ability to service debt from operating cash flows | Not reported here - calculate using trailing-12-month EBITDA |
| Interest Coverage (EBIT / Interest) | Shows margin of safety for interest payments | Not reported here - derive from income statement and notes |
| Current Ratio / Quick Ratio | Short-term liquidity indicators | Not reported here - compute from current assets / current liabilities |
- Practical next steps for investors: obtain the latest audited consolidated balance sheet and notes, check the most recent interim report for any new borrowings or equity events, and run the ratios above for trend analysis.
- Consider scenario analysis: model outcomes under higher leverage (e.g., debt/equity +50%) vs. deleveraging to assess cost of capital and financial flexibility impacts.
Sinodata Co., Ltd. (002657.SZ) - Liquidity and Solvency
As of September 30, 2025, Sinodata's reported short-term liquidity position shows a marked reduction in readily available cash and cash equivalents.- Cash and cash equivalents: CNY 393.94 million (decrease of 41.07% vs. prior period).
- Cash + short-term investments: CNY 393.94 million (same line item; down 41.07%).
- Accounts receivable: CNY 225.05 million - outstanding amounts tied up in operations.
| Item | Amount (CNY million) | Change vs. Prior Period |
|---|---|---|
| Cash & Cash Equivalents | 393.94 | -41.07% |
| Cash + Short‑term Investments | 393.94 | -41.07% |
| Accounts Receivable | 225.05 | - |
| Implied prior-period cash (estimate) | ~668.77 | - |
| Cash + AR (liquidity pool) | 618.99 | - |
- The 41.07% decline in cash reserves materially reduces the cushion available for meeting near-term obligations and funding operations.
- Accounts receivable of CNY 225.05 million represent cash conversion risk; slower collections would further strain liquidity.
- Monitoring liquidity ratios (current ratio, quick ratio, operating cash flow coverage) is essential to gauge short-term financial health; the reduced cash balance will negatively affect these ratios unless offset by lower short‑term liabilities or improved receivables turnover.
- Solvency assessment requires a deeper look at long-term liabilities, debt maturities and equity levels to determine whether the company can sustain operations and service long-term obligations.
Sinodata Co., Ltd. (002657.SZ) - Valuation Analysis
Key market valuation metrics for Sinodata Co., Ltd. as of November 5, 2025 spotlight a premium market view relative to peers and provide starting points for investor assessment.
| Metric | Value | Notes |
|---|---|---|
| Share price (date) | CNY 29.72 (Nov 5, 2025) | Latest quoted price for market-cap calculation |
| Market capitalization | CNY 10.44 billion | Based on the share price above |
| Price-to-Sales (P/S) | 8.87 | Indicates how the market values each yuan of revenue |
| Analyst target price | CNY 29.21 | Initiated coverage with an 'Outperform' rating |
| Analyst rating | Outperform | Coverage initiation note |
- High P/S of 8.87 signals a notably premium revenue multiple versus typical industry medians (often lower for comparable tech/data firms).
- Market cap of CNY 10.44 billion places Sinodata within the mid-cap segment of its exchange, but valuation multiples drive investor perception more than nominal size.
- Analyst target (CNY 29.21) slightly below the current price suggests limited near-term upside per that initiation, despite the 'Outperform' stance.
Important valuation considerations:
- Compare P/S and other multiples (P/E, EV/EBITDA where available) to direct peers to quantify the premium.
- Integrate profitability and growth metrics-revenue growth rate, gross margin, and operating margin-when interpreting high P/S levels.
- Monitor liquidity, order backlog, and contract pipeline that support revenue multiple justification.
For context on corporate direction and how strategy may underpin valuation, see the company's guiding documentation: Mission Statement, Vision, & Core Values (2026) of Sinodata Co., Ltd.
Sinodata Co., Ltd. (002657.SZ) - Risk Factors
Sinodata Co., Ltd. (002657.SZ) faces multiple near-term and structural risks that investors should weigh carefully. Key reported metrics for the first half of 2025 and market events highlight operating stress and capital-efficiency issues.| Metric | Value / Change | Period / Note |
|---|---|---|
| Net loss | -CNY 84.95 million | H1 2025 (increase of 71.51% YoY) |
| Net sales | Declining (year-over-year) | H1 2025 trend reported |
| Gross profit | Declined (absolute and margin contraction) | H1 2025 |
| Operating expenses | Increased (pressuring profitability) | H1 2025 |
| EBITDA | Negative | Recent reporting period |
| ROCE (Return on Capital Employed) | 0% | Indicates minimal/ no return on deployed capital |
| Stock price intraday move | -3.21% | 13 Oct 2025 (challenging session) |
- Profitability deterioration - Net loss widened to CNY 84.95M in H1 2025, up 71.51% YoY; falling gross profit plus higher opex drove most of the decline.
- Cash-flow and earnings quality - Negative EBITDA signals operations are not covering core cash costs; this raises liquidity and refinancing risk if sustained.
- Revenue pressure - Reported declining net sales reduce leverage to cover fixed costs, exacerbating margin compression.
- Capital efficiency - ROCE at 0% implies the company is not generating returns on employed capital, pointing to potential asset or capital-allocation inefficiencies.
- Market sentiment - A 3.21% drop on 13 Oct 2025 reflects investor concern; volatile trading can magnify funding and valuation pressures.
- Expense structure risks - Rising SG&A or R&D without corresponding revenue growth can lengthen the path to profitability recovery.
- Refinancing and covenant risk - Continued negative EBITDA and losses could tighten access to credit or breach covenants.
- Operational turnaround uncertainty - Management must arrest sales decline and restore gross margins; execution risk is material.
- Near-term monitoring checklist for investors:
- Quarterly revenue and gross-margin trends (are declines stabilizing?)
- EBITDA trajectory and cash-burn rate
- Any changes to capital structure, credit facilities, or covenant waivers
- Management commentary on cost-control, restructuring, or strategic pivots
- Share-price volatility and trading-volume spikes
Sinodata Co., Ltd. (002657.SZ) - Growth Opportunities
Sinodata's strategic pivot toward AI-native solutions and targeted expansion of computing power services creates multiple avenues for revenue acceleration and margin improvement. The firm has articulated an AI-Native technology architecture designed to support intelligent agents, while simultaneously exploring commoditized and value-added computing-power offerings to monetize AI workloads and serve enterprise clients.- AI-Native platform: infrastructure and software layers optimized for autonomous intelligent agents and large-model orchestration.
- Computing power services: capacity leasing, managed AI training/inference, and edge-cloud hybrid deployments aimed at cloud-native and enterprise AI demand.
- Fintech integration: AI-driven risk models, payment/settlement tooling, and data services that extend monetization opportunities beyond pure compute.
| Year | Projected Net Income (CNY billion) | YoY Growth |
|---|---|---|
| 2025 | 0.22 | - |
| 2026 | 0.50 | +127.3% |
| 2027 | 0.87 | +74.0% |
- Implied 2025-2027 CAGR in net income: ~98.9% (0.22 → 0.87 over two years).
- Step-change drivers assumed by analysts: ramp in computing-power utilization, higher-margin AI services, and cross-sell into fintech product lines.
- Adoption metrics for AI-native intelligent agents (number of enterprise deployments, average revenue per user/contract).
- Utilization rates and pricing trends for computing power services versus hyperscale cloud providers.
- Gross margin progression as software/AI services scale relative to hardware and energy costs.
- Regulatory and data-governance constraints affecting fintech and AI data monetization across jurisdictions.
- R&D and capital expenditures required to sustain the AI-Native architecture and data-center expansion.
- AI + fintech positioning allows Sinodata to capture both infrastructure (compute) and application-layer (fintech services) value - diversifying revenue mix and potentially expanding margins.
- Execution risk centers on pricing competition in compute, speed of enterprise AI adoption, and the company's ability to convert pilot projects into recurring contracts.
- Partnerships with cloud providers, chip vendors, and fintech incumbents will materially affect time-to-scale and unit economics.
Sinodata Co., Ltd. (002657.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.